Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / April 21, 2021 / Levi & Korsinsky, LLP announces that class actions have been filed on behalf of shareholders of the following publicly traded companies. Shareholders interested in acting as the main plaintiff have until the time limits indicated to apply to the court. For more details on the cases, see the links provided. There is no cost or obligation for you.

SOS shareholders Click here: https://www.zlk.com/pslra-1/sos-limited-information-request-form?prid=14981&wire=1
KRMD Shareholders Click here: https://www.zlk.com/pslra-1/repro-med-systems-inc-loss-submission-form?prid=14981&wire=1
EBS shareholders Click here: https://www.zlk.com/pslra-1/emergent-biosolutions-inc-loss-submission-form?prid=14981&wire=1

* ADDITIONAL INFORMATION BELOW *

SOS Limited (NYSE: SOS)

SOS legal action on behalf of: investors who bought from July 22, 2020 to February 25, 2021
Lead Applicant Deadline : June 1, 2021
TO FIND OUT MORE, VISIT: https://www.zlk.com/pslra-1/sos-limited-information-request-form?prid=14981&wire=1

According to the complaint filed, during the course period SOS Limited made materially false and / or misleading statements and / or did not disclose that: (i) SOS had misrepresented the true nature, location and / or l ‘existence of at least one of the principal management offices listed in its documents filed with the SEC; (ii) HY and FXK were undisclosed related parties and / or manufactured entities of the Company; (iii) the Company had misrepresented the type and / or existence of the mining platforms that it claimed to have purchased; and (iv) therefore, the Company’s public statements were materially false and misleading at all material times.

Repro Med Systems, Inc. (NASDAQ: KRMD)

KRMD lawsuit on behalf of: investors who bought from August 4, 2020 to January 25, 2021
Lead Applicant Deadline May 25, 2021
TO FIND OUT MORE, VISIT: https://www.zlk.com/pslra-1/repro-med-systems-inc-loss-submission-form?prid=14981&wire=1

According to the complaint filed, during the course period, Repro Med Systems, Inc. made materially false and / or misleading statements and / or did not disclose that: (1) as of January 2020, Repro Med Systems has intensified the use of allowances. , including growth discounts, to retain key customers and to encourage growth; (2) as the discounts accumulated, the company’s net sales were reasonably likely to decline; and (3) as a result of the foregoing, the positive statements by the defendants regarding the business, operations and prospects of the company were substantially misleading and / or lacked reasonable basis.

Emergent Biosolutions Inc. (NYSE: EBS)

EBS lawsuit on behalf of: investors who bought from July 6, 2020 to March 31, 2021
Lead Applicant Deadline June 18, 2021
TO FIND OUT MORE, VISIT: https://www.zlk.com/pslra-1/emergent-biosolutions-inc-loss-submission-form?prid=14981&wire=1

According to the complaint filed, during the class period, Emergent Biosolutions Inc. made materially false and / or misleading statements and / or did not disclose that: (i) the Emergent plant in Baltimore had a history of problems with manufacturing increasing the likelihood of massive contamination; (ii) these long-standing contamination risks and quality control issues at the Emergent facility have led to a series of citations from the FDA; (iii) the company previously had to throw away the equivalent of millions of doses of COVID-19 vaccine after workers at the Baltimore plant deviated from manufacturing standards; and (iv) as a result of the foregoing, the defendants’ public statements about Emergent’s ability and ability to mass-manufacture multiple COVID-19 vaccines at its Baltimore manufacturing site were materially false and / or misleading and / or lacked a reasonable basis.

You have until the lead applicant’s deadline to ask the court to appoint you as the lead applicant. Your ability to participate in any recovery does not require you to act as the principal applicant.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise and experience in representing investors in stock market litigation and recovered hundreds of millions of dollars for aggrieved shareholders. Lawyer advertising. Past results do not guarantee similar results.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th floor
New York, NY 10006
[email protected]
Phone: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

See the source version on accesswire.com:
https://www.accesswire.com/641626/CLASS-ACTION-UPDATE-for-SOS-KRMD-and-EBS-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of- Shareholders

About William W.

Check Also

The Valens Company Expands Domestic Reach With Yukon Territory Distribution Agreement | New

Valens can now ship products to five provinces and one territory in Canada KELOWNA, British …